Ann Marie Dale1, Bethany T Gardner, Angelique Zeringue, Robert Werner, Alfred Franzblau, Bradley Evanoff. 1. From the Department of General Medical Sciences (Dr Dale, Dr Gardner, Ms Zeringue, and Dr Evanoff), Washington University School of Medicine; School of Public Health (Ms Zeringue), St Louis University, St Louis, Mo; and Department of Environmental and Health Sciences (Dr Werner and Dr Franzblau), University of Michigan School of Public Health, Ann Arbor.
Abstract
OBJECTIVE: We evaluated post-offer pre-placement (POPP) nerve conduction studies (NCS) for carpal tunnel syndrome (CTS), testing diagnostic yield and cost-effectiveness. METHODS: A total of 1027 newly hired workers underwent baseline NCS and were followed for an average of 3.7 years for diagnosed CTS. Measures of diagnostic yield included sensitivity, specificity, and positive predictive value (PPV). Cost-effectiveness of POPP screening was evaluated using a range of inputs. RESULTS: Abnormal NCS was strongly associated with future CTS with univariate hazard ratios ranging from 2.95 to 11.25, depending on test parameters used. Nevertheless, PPV was poor, 6.4% to 18.5%. Cost-effectiveness of POPP varied with CTS case costs, screening costs, and NCS thresholds. CONCLUSIONS: Although abnormal NCS at hire increases risk of future CTS, the PPV is low, and POPP screening is not cost-effective to employers in most scenarios tested.
OBJECTIVE: We evaluated post-offer pre-placement (POPP) nerve conduction studies (NCS) for carpal tunnel syndrome (CTS), testing diagnostic yield and cost-effectiveness. METHODS: A total of 1027 newly hired workers underwent baseline NCS and were followed for an average of 3.7 years for diagnosed CTS. Measures of diagnostic yield included sensitivity, specificity, and positive predictive value (PPV). Cost-effectiveness of POPP screening was evaluated using a range of inputs. RESULTS: Abnormal NCS was strongly associated with future CTS with univariate hazard ratios ranging from 2.95 to 11.25, depending on test parameters used. Nevertheless, PPV was poor, 6.4% to 18.5%. Cost-effectiveness of POPP varied with CTS case costs, screening costs, and NCS thresholds. CONCLUSIONS: Although abnormal NCS at hire increases risk of future CTS, the PPV is low, and POPP screening is not cost-effective to employers in most scenarios tested.
Authors: V Chaudhry; D R Cornblath; E D Mellits; O Avila; M L Freimer; J D Glass; J Reim; G V Ronnett; S A Quaskey; R W Kuncl Journal: Ann Neurol Date: 1991-12 Impact factor: 10.422
Authors: Susan Burt; James A Deddens; Ken Crombie; Yan Jin; Steve Wurzelbacher; Jessica Ramsey Journal: Occup Environ Med Date: 2013-06-20 Impact factor: 4.402
Authors: Ann Marie Dale; Bethany T Gardner; Skye Buckner-Petty; Jaime R Strickland; Bradley Evanoff Journal: J Occup Environ Med Date: 2016-12 Impact factor: 2.162
Authors: Ann Marie Dale; Folasade Agboola; Amber Yun; Angelique Zeringue; Muhammed T Al-Lozi; Bradley Evanoff Journal: PM R Date: 2014-10-15 Impact factor: 2.298